Abstract
Introduction A significant number of patients continue to recover from COVID-19; however, little is known about the lung function capacity among survivors. We aim to determine the long-term impact on lung function capacity in patients who have survived moderate or severe COVID-19 disease in a resource-poor setting.
Methods and analysis This prospective cohort study will include patients aged 15 years and above and have reverse transcriptase-polymerase chain reaction (RT-PCR) positive for COVID 19 (nasopharyngeal or oropharyngeal). Patients with a pre-existing diagnosis of obstructive or interstitial lung disease, lung fibrosis and cancers, connective tissue disorders, autoimmune conditions affecting the lungs, underlying heart disease, history of syncope and refuse to participate will be excluded. Pulmonary function will be assessed using spirometry and diffusion lung capacity for carbon monoxide (DLCO) at three- and six-months interval. A chest X-ray at three and six-month follow-up and CT-chest will be performed if clinically indicated after consultation with the study pulmonologist or Infectious Disease (ID) physician. Echocardiogram (ECHO) to look for pulmonary hypertension at the three months visit and repeated at six months if any abnormality is identified initially. Data analysis will be performed using standard statistical software.
Ethics and dissemination The proposal was reviewed and approved by ethics review committee (ERC) of the institution (ERC reference number 2020-4735-11311). Informed consent will be obtained from each study participant. The results will be disseminated among study participants, institutional, provincial and national level through seminars and presentations. Moreover, the scientific findings will be published in high-impact peer-reviewed medical journals.
Strengths and Limitations of this study
- The study has the potential to develop context-specific evidence on the long-term impact on lung function among COVID-19 survivors
- Findings will play key role in understanding the impact of the disease on vital functions and help devise rehabilitative strategies to best overcome the effects of disease
- This is a single-center, study recruiting only a limited number of COVID-19 survivors
- The study participants may loss-to-follow up due to uncertain conditions and disease reemergence
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is not a clinical trial
Funding Statement
The study is funded through a grant from the Bill and Melinda Gates Foundation, grant no: (OPP1176356). The funders had no role in the study design
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Review Committee, Aga Khan University, Karachi, Pakistan
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors Email ID: sonia.qureshi{at}aku.edu, nosheen.nasir{at}aku.edu, naveed.rashid{at}aku.edu, naveed.ahmed{at}aku.edu, zoyaqamarhaq{at}gmail.com, farah.qamar{at}aku.edu.
Data Availability
The datasets generated during the current study will be available from the corresponding author on reasonable request
Abbreviations
- AKUH
- Aga Khan University Hospital
- RT-PCR
- Reverse Transcriptase Polymerase Chain Reaction
- DLCO
- Diffusion Lung capacity for Carbon Monoxide
- ID
- Infectious Disease
- ECHO
- Echocardiogram
- ERC
- Ethical Review Committee
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- WHO
- World Health Organization
- MERS-CoV
- Middle East Respiratory Syndrome Coronavirus
- SOPs
- Standard Operating Procedures
- ARDS
- Acute Respiratory Distress Syndrome
- CT
- Computed Tomography
- COPD
- Chronic Obstructive Pulmonary Disease
- ATS
- American Thoracic Society
- qSOFA
- quick Sequential Organ Failure Assessment
- ICU
- Intensive Care Unit
- HDU
- High Dependency Unit
